Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

NANDROLONE DECANOATE

NANDROLONE DECANOATE

Standard Dose
200MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NANDROLONE DECANOATE is listed in Drugs@FDA under application 091252 (ANDA).

Marketing status: Discontinued Active ingredient NANDROLONE DECANOATE Form and strength INJECTABLE;INJECTION - 200MG/ML Sponsor AM REGENT Submission history Latest submission status date: 2010-08-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview NANDROLONE DECANOATE is listed in Drugs@FDA under application 091252 (ANDA). Marketing status: Discontinued Active ingredient NANDROLONE DECANOATE Form and strength INJECTABLE;INJECTION - 200MG/ML Sponsor AM REGENT Submission history Latest submission status date: 2010-08-30 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
NANDROLONE DECANOATE (NANDROLONE DECANOATE) | Drug Monograph | MedicHelpline